Related Experiment Video
Updated: May 17, 2026

08:51
Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts
Published on: May 12, 2019
Cyanide binding to human plasma heme-hemopexin: a comparative study.
Paolo Ascenzi1, Loris Leboffe, Fabio Polticelli
1Laboratorio Interdipartimentale di Microscopia Elettronica, Università Roma Tre, Roma, Italy. ascenzi@uniroma3.it
Biochemical and Biophysical Research Communications
|October 17, 2012
Summary
This study investigates cyanide binding kinetics and thermodynamics to human hemopexin-heme-iron complexes. Results reveal key parameters influencing heme iron reactivity and reduction processes.
Area of Science:
- Biochemistry
- Biophysical Chemistry
- Metalloprotein Chemistry
Background:
- Hemopexin (HPX) is crucial for scavenging and delivering heme-iron.
- HPX-heme-iron complexes exhibit unique spectroscopic and reactivity properties.
- Understanding these properties is vital for heme metabolism research.
Purpose of the Study:
- To determine the kinetics and thermodynamics of cyanide binding to ferric and ferrous human plasma HPX-heme-Fe.
- To investigate the reduction kinetics of the ferric HPX-heme-Fe-cyanide complex.
- To elucidate the role of amino acid residues in modulating HPX-heme-Fe reactivity.
Main Methods:
- Spectroscopic analysis of cyanide binding to HHPX-heme-Fe(III) and HHPX-heme-Fe(II).
- Kinetic measurements for cyanide association and dissociation rates.
- Dithionite-mediated reduction assays for the HHPX-heme-Fe(III)-cyanide complex.
Main Results:
- Quantified thermodynamic and kinetic parameters for cyanide binding to both HHPX-heme-Fe(III) and HHPX-heme-Fe(II).
- Determined the rate constant for the dithionite-mediated reduction of HHPX-heme-Fe(III)-cyanide.
- Identified the involvement of amino acid residues like His236 in ligand protonation/deprotonation.
Conclusions:
- Cyanide binding kinetics and thermodynamics to HHPX-heme-Fe have been characterized.
- The reduction of HHPX-heme-Fe(III)-cyanide is a defined kinetic process.
- HPX-heme-Fe reactivity is influenced by specific amino acid residues facilitating ligand exchange.
Related Concept Videos
Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Hemoglobin
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Oxygen Transport in the Blood
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Drug Distribution: Plasma Protein Binding
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...

